Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00514852 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye
A NA study, sponsored by Allergan.
- Completed
- Registry status
- NA
- Development phase
- 316
- Enrollment target
NCT00514852: Completed NA study, sponsored by Allergan.
NCT00514852 is a NA study that has completed, run by Allergan. The registered enrollment target is 316 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00514852, a NA study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- NA
- Development phase
- 316 participants
- Enrollment target
Study Summary
The efficacy, safety and acceptability of a new artificial tear in subjects with dry eye will be compared to a currently-available artificial tear
Primary Outcome
Ocular Surface Disease Index© Questionnaire Score is measured on 12 domains; a 5-point scale (0-4) for each domain. Sum of the domain scores is normalized to a severity scale of 0-100 (0 = no symptoms, 100 = maximum severity)
Interventions
- DRUG Carboxymethylcellulose and Glycerin based artificial tear
- DRUG Carboxymethylcellulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-01 |
| Phase | NA |
What the finished NCT00514852 record still lists
NCT00514852 is an interventional study that assigns participants to a tested intervention. The registered 316 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Carboxymethylcellulose and Glycerin based artificial tear is the first listed.
NCT00514852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00514852 about?
NCT00514852 is a clinical study titled "Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye". The efficacy, safety and acceptability of a new artificial tear in subjects with dry eye will be compared to a currently-available artificial tear
What is the current status of trial NCT00514852?
This trial is currently completed. It is a NA study. The enrollment target is 316 participants. The study started on 2007-10. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00514852?
The interventions under investigation include: Carboxymethylcellulose and Glycerin based artificial tear (DRUG), Carboxymethylcellulose (DRUG).
Who is sponsoring clinical trial NCT00514852?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00514852's enrollment target sits among peer trials
316 321st of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04256317 · 316 participants · Phase 2
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- NCT04787042 · 316 participants · Phase 1
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- NCT04802759 · 316 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- NCT05464056 · 316 participants · NA
BUILT Family Lifestyle Program for Children with ADHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia